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ABSTRACT 
Mammalian circadian rhythms are controlled by the suprachiasmatic nuclei (SCN) of the 
hypothalamus. While neural circuits influence SCN entrainment, cells within the SCN also 
act as individual oscillators. Research on mechanisms that regulate synchronization of 
ensemble SCN rhythms has mainly focused on neuronal populations. However, astrocytes 
are just as abundant in the SCN and display circadian rhythms in clock gene expression 
and extracellular accumulation of ATP. Rhythmic accumulation of ATP in the rat SCN in 
vivo has also been described to occur during the night. Nonetheless, it remains unclear 
whether or not astrocytic ATP release functions as a synchronizing signal in the SCN and 
contributes to ensemble neural activities such as inflammatory signaling. Preliminary 
studies on SCN cell cultures and purinergic inhibitors disrupt ATP accumulation and clock 
gene expression rhythms. Further, clock-defective astrocytes are unable to accumulate 
ATP rhythmically. I tested the hypothesis that ATP signaling mediates rhythms in 
astrocytic physiology through P2X7 receptor. First, I tested whether rhythmic ATP release 
may synchronize individual oscillators in the SCN cells. I also tested the effectiveness of 
BzATP, a P2X7R agonist, in inducing release of ATP in mouse SCN cells. I tested if 
P2X7R, GFAP overall protein expression and astrocytic activation markers such as GFAP, 
are rhythmic in mouse SCN cells. I demonstrate that ATP signaling among astrocytes is a 
good candidate for a coordinating mechanism that synchronizes clock-controlled 
physiological responses in the SCN and other brain regions. Furthermore, I present data 
indicating that clock-controlled ATP signaling rhythms are involved in modulating 
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neuroinflammatory signaling. Since BzATP proved to be an effective P2X7R agonist with 
regard to potentiating ATP release from mouse SCN cells, further experiments with other 
agonists and antagonists can provide evidence for the role of ATP and P2X7R signaling 
rhythms, their circadian regulation, and their influence on astrocytic physiology and brain 
health. 
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INTRODUCTION 
Rhythmic gene expression has been described in organisms as diverse as animals, fungi, 
plants, bacteria and archaea.  These gene expression rhythms and the biological clocks 
that underlie them are necessary in order to survive environmental fluctuations 
(Whitehead et al. 2009). Since temporal regulation of organismal physiology is necessary 
for each of these groups, they all possess common modulators that coordinate biological 
timing processes to anticipate environmental changes. These common modulators are 
highly conserved auto-regulatory feedback mechanisms, based on diverse molecular clock 
components. The way these internal molecular clocks keep time is by activating and/or 
gating transcription, translation or other modulatory processes that translate into rhythmic 
behavioral activities (Bell-Pedersen et al. 2005). Mammals, being multicellular organisms, 
depend on a master circadian pacemaker located in the brain to coordinate and synchronize 
other oscillators throughout the body. These central neural pacemaker regions located in 
the hypothalamus are the suprachiasmatic nuclei (SCN).  This chapter will introduce the 
SCN, with a particular focus on rhythmic astrocyte physiology. Astrocytes in the SCN are 
known to have a peak in release of ATP every 24 hours (Womac et al. 2009). Since 
astrocytes also possess internal molecular clocks that are synchronized across an ensemble 
glial population, this thesis will describe experiments investigating the role of the 
purinergic receptor P2X7 in regulating the astrocyte synchronization and clock controlled 
ATP- accumulation in SCN-derived cell cultures. 
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Suprachiasmatic nucleus 
Biological clocks establish physiological and behavioral rhythms synchronized at 
appropriate times of the day in order to secure organismal survival. In mammals, the 
suprachiasmatic nuclei (SCN) synchronizes these daily rhythms to the photoperiodic time 
of day. Since the SCN acts as a bridge between the environmental light-dark cycle and the 
rest of the body, it is directly connected to the eyes through the retinohypothalamic tract 
(RHT) via the optic nerve (Hastings & Herzog 2004). The eyes receive photic cues that 
are detected by melanopsin photopigment in specific cells of the retina (Nayak et al. 2001). 
Intrinsically photosensitive retinal ganglion cells (ipRGCs) that express melanopsin, 
project from the retina to the SCN and are responsible for circadian photoentrainment by 
releasing glutamate and pituitary adenylate cyclase-activating polypeptide (PACAP) onto 
the SCN neurons (Lowrey & Takahashi 2004). There are other neurotransmitters released 
by ipRGCs but glutamate and PACAP have been studied intensively since they have 
distinct roles in regulating entrainment.  Studies have shown that exogenous application 
of glutamate mimics light-induced phase shifts in activity, and the use of N-methyl-D-
aspartate receptor (NMDA) antagonists blocks those phase shifts (Golombek & 
Rosenstein 2010).  Glutamate is also involved in further signal transduction events like 
activation of Ca2+/calmodulin-dependent protein kinase type II (CaMKII), nitric oxide 
release, and CREB activated transcription (Cheng & Obrietan 2008). PACAP also 
activates signaling through transduction pathways like cAMP/PKA, PKC, MAPK 
cascades and triggers release of Ca2+from intracellular stores (Michel et al. 2006). PACAP 
has a complex modulatory role since it has been found that its capacity to affect gene 
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expression is inversely related to its concentration. Very small amounts (pM) potentiate 
NMDA channel conductance, nanomolar amounts induce Per1 and Per2 expression, and 
micromolar concentrations of PACAP facilitate glutamate-induced transcription of Per1 
and Per2 (Nielsen et al. 2001).  
In terms of neuronal heterogeneity, the SCN has been separated into two distinct 
areas, the core region (ventrolateral) and the shell region (dorsomedial).  The core receives 
direct input from the retina, intergeniculate leaflet and raphe nuclei (Moga & Moore 
1997). The core also extensively innervates the shell, while lesser innervation occurs from 
the shell back to the core. While the SCN shell is characterized by high expression of 
arginine vasopressin (AVP) and metenkephalin the core neurons mainly express 
vasoactive intestinal polypeptide (VIP), gastrin-related peptide (GRP) and calbindin (Yan 
et al. 2007). GABAergic transmission is also prevalent in the SCN. The SCN core, upon 
receiving photic cues through the RHT, entrains neighboring neurons of the shell and other 
regions in the brain (Hastings & Herzog 2004). After the shell becomes entrained though 
core input, it then communicates with other target areas of hypothalamus (eg., medial 
subparaventricular zone, the preoptic area, and dorsomedial hypothalamus) and drives 
rhythmic outputs in neural circuits through its synchronous firing patterns. Rhythms in 
SCN neuronal firing are thought to underlie its ability to synchronize other brain areas. 
However, other mechanisms such as hormones or diffusible signals are required for 
entraining peripheral oscillators via synchronizing cues (Allen et al. 2001). Some 
candidates include the hormones such as cortisol and melatonin and the diffusible signals 
such as prokineticin 2, transforming growth factor-α (TGF- α) and cardiotrophin-like 
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cytokine (CLC) (Yan et al. 2007, Kraves & Weitz 2006). 
Mammalian biological clock 
The SCN’s neuronal heterogeneity and its neural circuitry certainly contributes to how the 
SCN operates in terms of synchronization, but the cellular clock that keeps time within 
individual neurons is critical to this synchronization. Since the identification of the 
Circadian Locomotor Output Cycles Kaput (Clock) gene in 1997, other genes have been 
shown to be part of the mammalian core transcription-translation feedback loop. It is also 
known that the core molecular clock of the SCN is essential for entrained mammalian 
circadian rhythms (King et al. 1997, Herzog et al 1998). The “positive limb” of this loop 
is composed of two Period-Arnt-Single-minded (PAS) helix-loop-helix transcription 
factors, Clock/Npas2, and the brain and muscle ARNT-like protein 1 (Bmal1/Mop3) 
(Preitner et al. 2002). After CLOCK and BMAL1 hetero-dimerize in the cytoplasm and 
translocate into the nucleus, they activate transcription of other genes by binding E-box 
elements in their promoters. Therefore, they are positive regulators. Some of those 
activated genes are three Period (per1, per2, per3), two Cryptochrome (cry1 and cry2), 
Rev-Erba and ROR-A genes (Lee et al. 2001, Sato et al. 2004). After PER and CRY are 
translated they also form a heterodimer and make up the “negative limb” of the loop, since 
they further translocate into the nucleus and inhibit CLOCK:BMAL1 transcriptional 
function. This causes PER:CRY levels to decrease due to low transcriptional activity and 
degradation of the proteins, after which the feedback loop is completed (Buhr & Takahashi 
2013). A second negative feedback loop is orphan nuclear receptors REV-ERBα & REV-
ERBβ and retinoic acid-related orphan receptor RORα, which inhibit and activate Bmal1 
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transcription respectively (Lowrey & Takahashi 2004). Both proteins bind to retinoic acid 
related orphan receptor response elements (ROREs) in the Bmal1 promoter (Preitner et al. 
2002, Ko & Takahashi 2006). Other proteins involved in circadian regulation are the ones 
that carry out posttranslational regulation on core clock genes, such as casein kinase 1 
epsilon (CK1ε), which have overlapping functions (Etchegaray et al. 2009). CK1ε, first 
identified as tau, and CK1δ are involved in the phosphorylation, destabilization and further 
degradation of PER while it is in the cytoplasm, as well as in translocating the PER:CRY 
into the nucleus (Ralph & Menaker 1998, Camacho et al. 2001).  
Glial communication 
Astrocytes are one of the most abundant cells in the central nervous system (CNS), 
especially in the hypothalamus and SCN. They have distinct morphology, biochemical 
properties and functions.  Astrocytes are usually found surrounding brain capillaries and 
neurons near sites of synaptic connections. At the synapse, astrocytes can provide nutrients 
like glucose or lactate and regulate levels of neurotransmitters to avoid excitotoxicity 
(Tsacopoulos & Magistretti 1996, Rothstein et al 1996). Astrocytes also promote CNS 
synaptogenesis, while Schawnn cells promote it in the peripheral nervous system (PNS), 
as well as maintaining or eliminating those synapses during development and regeneration 
(Ullian et al. 2004, Sanes & Lichtman 1999, Nägler et al. 2001). Astrocytes can also 
release transmitters that act upon synapses modulating neurotransmission and electrical 
communication (Parpura & Haydon 2000). Through gliotransmission, astrocytes are able 
to communicate with neurons and other astrocytes to contribute to modulation of brain 
physiology (Araque et al. 1999). Although astrocytes are unable to generate action 
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potentials, they can communicate with other astrocytes via gap junctions, gliotransmitters 
and “excitable” Ca2+ waves (Araque et al. 1999). Calcium wave propagation among 
astrocytes is mediated by inositol-4,5-triphosphate (IP3) pathway and release of Ca2+ from 
internal stores (De Pitta et al. 2009).  Astrocytes respond to neuronal activity, as well as 
gap junctional or purinergic signaling from other glial cells (Guthrie et al. 1999). After IP3 
diffuses through gap junctions or ATP is elevated, IP3 increases its binding to receptors on 
the endoplasmic reticulum (ER) that release intracellular Ca2+ into the cytoplasm. As 
intracellular calcium increases, it travels to neighboring astrocytes through gap junctions 
and activates further IP3 receptors and more participating glial cells. Furthermore, with an 
intracellular rise in calcium, astrocytes are able to release gliotransmitters, and 
communicate with pre- and postsynaptic neurons. Thus, astrocytes participate in the 
tripartite synapse. 
SCN astrocytes produce Ca2+ oscillations that respond to different 
neurotransmitters like glutamate and serotonin, suggesting a role in modulation of 
neurotransmission and clock regulation (van den Pol et al 1992). Since astrocytes also 
posses the canonical mammalian molecular clock, they have rhythmic gene expression as 
independent oscillators (Prolo et al. 2005). ATP evokes a Ca2+ rise among astrocytes and 
may be involved in neuron-astrocyte communication in the SCN (Guthrie et al. 1999). It 
has been shown that cultured SCN astrocytes display 24-hour rhythms in extracellular 
accumulation of ATP (Womac et al. 2009) (Fig. 1). Although the exact mechanism of 
clock-controlled ATP release from astrocytes has not been fully defined, it is thought to 
not be through vesicular release (Marpegan et al. 2011). It is also known that the rhythms 
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in ATP accumulation levels and mitochondrial calcium are in phase, and that ER calcium 
stores are not required for the rhythmic extracellular ATP accumulation (Burkeen et al. 
2011). 
Figure 1. Circadian rhythm of extracellular ATP accumulation in rat 
SCN2.2 cells. Rhythm continues for at least 3 cycles with a period (τ) of 
23.7 h and a rhythm amplitude between 1 pM and 1 nM. (Adapted from 
Womac et al. 2009).  
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Astrocytic activation 
While ATP signaling among astrocytes is primarily known to be involved in intercellular 
calcium wave propagation, it is also involved in astrocyte-microglia communication. 
Microglia, the macrophages of the CNS, modulate and carry out diverse immune 
responses in the brain such as phagocytosis and release of cytokines. Both astrocytes and 
microglia can become reactive and enter a gliosis state that causes neuroinflammation. 
Although inflammation promotes beneficial processes like phagocytosis of debris and/or 
apoptotic cells and tissue repair processes, constant neuroinflammation causes a toxic 
environment for the brain. Neuroinflammation is commonly associated with neural 
trauma, neurodegenerative disorders and age-related neurological diseases (Steelman & 
Li 2014). Illnesses like Parkinson’s disease (PD) and Alzheimer’s disease (AD) are 
associated with increased numbers of reactive microglia and astrocytes, which play 
important roles in the development of neuroinflammation (Glass et al. 2010). Another 
common factor among these age-related diseases, besides enhanced neuroinflammation, 
is clock defects. Bmal1 deletion in the SCN and other brain regions leads to upregulated 
glial fibrillary acidic protein (GFAP) expression in an age-dependent manner. This causes 
severe astrogliosis as well as accelerated aging and cognitive deficits (Musiek et al 2013, 
Duncan et al. 2013). In older mice, there is also increased sensitivity of astrocytes and 
microglia to cytokine exposure, highly marked in the SCN (Deng et al. 2010). The 
relationship between astrocyte activation and the biological clock suggest the existence of 
a homeostatic regulation of the brain with respect to purinergic signaling, since the P2X7 
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purinergic receptor of both brain inflammation and circadian ATP release rhythms is 
present in astrocytes. 
Purinergic signaling 
This project has attempted to discern if ATP signaling is involved in rhythmic oscillations 
of astrocytic activation. We have hypothesized that the purinoreceptor 2X7 (P2X7R) 
expressed in neurons, astrocytes and microglia, plays a key role in clock-controlled ATP 
accumulation rhythm (Jarvis & Khakh 2009). Previous data has suggested that the 
blockage of P2X7R with Brilliant Blue G (BBG) antagonist causes a decrease in the ATP 
accumulation rhythm in SCN2.2 cells, as well as dampening of PER2 expression rhythms 
on mPer2Luc cells (Fig. 2A, 2B). 
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Figure 2. Effects of inhibition of purinergic signaling on extracellular ATP 
and expression of a Per2 reporter gene. A) Rhythms in extracellular ATP are 
inhibited with the application of P2X7 purinergic receptor inhibitor BBG, 
but facilitated by the P2Y1 receptor inhibitor MRS. B) The bioluminescence 
rhythm of Per2- luciferase reporter gene is dampened and its amplitude is 
significantly decreased with BBG disruption of ATP-P2X7R ligand-receptor 
interaction (Adapted from Womac et al. unpublished).  
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Nonetheless, research on P2X7R in glia has been mainly focused on its role in astrocytic 
activation by interleukin-1β (IL-1β) release especially from astrocyte-induced microglia 
in vitro and in association in the so called death complex with the hemichannel Pannexin 
1 (PANX1) (Bianco et al. 2005, Jackson et al. 2014).  ATP is released through anion-
selective PANX1 channels activated by a cation-selective P2X7 receptor channel in 
astrocytes (Iglesias et al. 2008, Iglesias et al. 2009, Verkhratsky et al. 2012). P2X7R 
activation is known to trigger elevations in Ca2+ in neural cells and these increases in 
cytoplasmic calcium in turn activate PANX1 (Mitchell et al. 2008, Egan & Khakh 2004). 
Also, PANX1 auto-regulates its own ATP permeability through a negative feedback loop 
causing transient ATP release (Qiu & Dahl 2009) (Fig. 3). In addition, the astrocytic 
activation marker, GFAP, is rhythmic in SCN astrocytes and has been linked to 
morphological changes in astrocytes (La vialle & Serviere 1993).  
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Figure 3. Schema suggested by the use of P2X7R agonist BzATP and 
antagonist BBG. ATP binding to P2X7R triggers calcium elevations in the 
cytoplasm of astrocytes, while PANX1 is an established channel for the 
release of ATP, particularly following P2X7R activation. BzATP and BBG 
drugs act by activating and inhibiting P2X7R, respectively.  
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Astrocyte activation in the SCN, as well as locomotor activity, can be phase-shifted with 
lipopolysaccharide (LPS) application, a bacterial endotoxin used to elicit a strong immune 
response (Marpegan et al. 2005). LPS causes changes in sleep/wake patterns in which 
susceptibility to the endotoxin depends on time of application (Marpegan et al. 2005). 
Also, the expression of transcription factor nuclear factor κB (NF-κB) is induced by LPS 
in SCN astrocytes (Leone et al 2006). Other studies have showed that the astrocytic 
activation marker, cytokine tumor necrosis factor α (TNF-α), alters phase and amplitude 
of PER2 rhythms in SCN astrocytes and PER1 rhythms in NIH/3T3 fibroblast cell line 
(Duhart et al. 2010). Together, these results suggest a role for SCN astrocytes in the 
circadian modulation of immune responses and brain cytokine levels. It is possible that 
ATP signaling through the P2X7R modulates clock controlled immune mechanisms. ATP 
may also be an important signaling molecule involved in circadian timing and 
synchronization between astrocyte-astrocyte or astrocyte-neuron communication in the 
SCN and other brain regions.  Thus, I have tested the hypothesis that purinergic signaling, 
through P2X7R, mediates circadian astrocyte physiology, specifically rhythmic and 
synchronous activation of astrocyte populations. 
Experiments in this project have used in vitro models of immortalized cell lines, 
rat SCN2.2 and mouse Per2Luc SCN, which contain both neuronal and glial cell types 
(Earnest et al. 1999, Allen et al. 2001, Farnell et al. 2011). These SCN cell lines were 
created, characterized and graciously provided by Dr. David Earnest. SCN cell lines 
conserve endogenous circadian properties and provide a good model system to study 
mechanisms of clock-controlled physiology in vitro, such as rhythmic ATP accumulation 
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and astrocytic activation. The immortalized cell line with the mPERIOD2::LUCIFERASE 
fusion protein has been used as a real-time reporter of circadian rhythms as analyzed with 
the LumiCycle luminometer. I have performed these experiments to further understand 
brain inflammation and its circadian regulation through astrocytic signaling. I 
hypothesized that P2X7R mediates the rhythmic ATP accumulation rhythm as well as 
rhythmic and synchronous activation of SCN astrocytes. First, I determined that these 
rhythms in extracellular ATP accumulation are present in mouse SCN cells. Then I 
investigated the role of P2X7R in ATP rhythmic release by studying its activation by ATP 
and BzATP [2'(3')-O-(4-Benzoylbenzoyl) adenosine-5'-triphosphate], a specific P2X7R 
agonist (El-Moatassim & Dubyak 1992, Nuttle et al. 1993, Iglesias et al. 2008).  Finally, 
I studied rhythmicity in astrocyte activation using GFAP expression and IL-1β signaling 
by P2X7R activation with BzATP.  
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MATERIALS AND METHODS 
 
Cell culture conditions 
Rat SCN2.2 cultures were grown in 60mm dishes (Corning, Corning, NY, USA) using 
Minimum Essential Medium (MEM; Invitrogen, Carlsbad, CA and MEM; Caisson, 
Logan, UT, USA) supplemented with 10% fetal bovine serum (FBS), glucose 
(3000µg/ml), L-glutamine (292µg/ml), and 1% penicillin-streptomycin-neomycin 
antibiotics mixture (PSN; Gibco/Invitrogen, Grand Island, NY, USA) (Earnest et al. 
1999).    The culture dishes were maintained at 37°C and 5% CO2, and were split every 2 
days. The media was replaced at 48hr intervals. For all experiments SCN2.2 cells were 
derived from a single passage (Farnell et al. 2011). Cultures of SCN mPer2Luc cells were 
grown under the same media conditions, temperature and CO2 level as SCN2.2 cells. 
During cell propagation, the cultures were split every 3 days, and the media changed at 
72-hour intervals. For all experiments mPer2Luc cells were derived from a single passage 
and were propagated as described above. SCN mPer2Luc cells grown for 
immunocytochemistry were plated onto 2-well Nunc glass-coverslip chamber slides (Lab-
Tek, Thermo Fisher Scientific, Rochester, NY, USA) previously coated with Poly-D-
lysine hydrobromide and laminin (Sigma Aldrich, St. Louis, MO, USA) and then allowed 
to grow to confluence (2 days). SCN mPer2Luc cells grown for luminometry analysis were 
seeded onto 35mm dishes (Corning, Corning, NY, USA) and allowed to grow to 
confluence (2 days). 
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Chemiluminescence assay for analysis of ATP levels in culture media 
To analyze ATP levels from SCN2.2 and SCN mPer2Luc cells, chemiluminescence assays 
of cell-free media were performed by incubating aliquots (97µl) of media samples with 1 
µl of luciferase (3 mg/ml) and 2 µl of luciferin (3 mg/ml) per well in black 96-well plates 
(Thermo, Milford, MA, USA). Internal controls consisting of unconditioned medium 
without ATP standard, luciferase, or luciferin were included on all analyzed plates. ATP-
dependent chemiluminescence produced by medium samples was quantified using a 
Packard TopCount scintillation counter (Meriden, CT, USA). 
Serum reduction protocol for chemiluminescence 
 SCN2.2 and SCN mPer2Luc cells used for analysis of ATP levels through 
chemiluminescence assays were subjected to a serum reduction (SR) procedure, since the 
chemiluminescence assay is dramatically disrupted by the presence of serum. After cells 
were previously grown and expanded from one single passage, all cell cultures were then 
plated onto 60mm dishes with 10% serum. After 24-hour period, the serum concentration 
was reduced to 5%. Another 24 hours later the media was replaced with serum-free 
neurobasal medium (supplemented with glucose, L-glutamine, and 1X B-27 serum- free 
supplement; Invitrogen). Finally, 2 hours later, the experimental analysis was initiated by 
collecting and replacing medium (500ul) from all culture dishes at 2- hour intervals for 72 
hours. Samples were frozen and stored at -20°C and later analyzed for ATP accumulation 
using the chemiluminescence assay previously described. It is noteworthy that every step 
of serum reduction has to be done in exactly 24 hour intervals to keep all cells in synchrony 
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without serum shock or forskolin (FSK). 
Acute effects of BzATP on extracellular ATP accumulation rhythms 
To observe the immediate effects of BzATP (Tocris, Minneapolis, MN, USA) on ATP 
levels, cultures were allowed to reach confluence. After SR was performed, cultures were 
subjected to ATP (10nM), BzATP (10nM or 100µM) application, as well as dishes without 
cells and only neurobasal medium. The first medium sample (500µl) was collected before 
the drug application, then 5 min after of BzATP/ATP application, then 30 min, and finally 
60 min later without replacing the medium. Samples were frozen and stored at -20°C and 
later analyzed for ATP accumulation using the chemiluminescence assay. 
A dose response analysis was performed in order to determine the effectiveness of 
BzATP as an ATP analog in the luciferase/luciferin reaction by providing a direct 
substrate for chemiluminescence assay. Using different concentrations of ATP (10nM, 
100nM, 1µM, 10µM,  100µM & 1mM) and BzATP (10nM, 100nM, 1µM, 10µM, 100µM 
& 1mM) in addition to luciferase/luciferin, a chemiluminescence assay was performed to 
compare the light intensity produced by ATP and BzATP. Note that only some aspects of 
this larger dose response analysis are presented in the results section of this thesis. 
Effects of exogenous ATP application on extracellular ATP accumulation rhythms 
ATP accumulation rhythms in SCN2.2 cells were analyzed during a 72-hour time course. 
After cells cultures were expanded, media samples were collected at intervals of 2 hours. 
At 6 hours and 16 hours, independent dishes received exogenous ATP (10nM), elevating 
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the ATP concentration of the endogenous rhythm. Samples were frozen and stored at -
20°C and later analyzed for ATP accumulation using the chemiluminescence assay 
previously described. 
Effects of BzATP application on extracellular ATP accumulation rhythms 
The ATP accumulation rhythm in mPer2Luc cells was analyzed during 72-hour time 
course. After cells were grown and underwent SR procedure, samples were collected at 
intervals of 2 hours. At 6 hours, independent dishes received BzATP (100µM). Samples 
were frozen and stored at -20°C and later analyzed for ATP accumulation using the 
chemiluminescence assay previously described. 
Immunocytochemistry 
For immunocytochemical analyses of P2X7 receptor and GFAP expression, SCN 
mPer2Luc cells were seeded onto glass-coverslip chamber slides and allowed to grow to 
confluence (1-2 days). Individual cultures were fixed for 15 min with 4% 
paraformaldehyde in with phosphate buffered saline (PBS; Invitrogen) at 4-hour intervals 
for 48 hours. Cells were washed with PBS, and permeabilized with PBS containing 1% 
Tween-20 for 10 min. Cells were then incubated for 30 min with blocking solution 
containing PBS, 1% Tween and 10% fetal goat serum. Dishes were incubated 24 hours 
with primary antibodies (rabbit anti-P2X7R or rabbit anti-GFAP) both diluted 1:100 in 
blocking solution. Cells were washed and then incubated for 24 hours with goat anti-rabbit 
Alexa Fluor 488 IgG (Invitrogen) diluted 1:500 in blocking solution. Images were 
captured with a Olympus fluorescence microscope using 30x magnification with 
background subtraction. Then images were analyzed using grey level intensity 
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measurements with Simple PCI 4.0 imaging software (Compix, Cranberry Township, 
PA).  
ELISA 
For quantification of cytokine IL-1β, SCN mPer2Luc cells were grown in 60mm dishes and 
subjected to the SR protocol. During the 24 hours following SR procedure, samples of 
medium were collected at intervals of 6 hours. Samples were stored at -20°C and later 
analyzed using a mouse IL-1β/ IL-1F2 immunoassay. The assay was performed according 
to manufacturer instructions (Quantikine ELISA, R&D Systems, Minneapolis, MN) and 
analyzed at 540nm on a Bio-Rad (Hercules, CA) Bio-Plex system employing Luminex 
technology. 
Statistics 
Raw chemiluminescence data (photons/sec) for SCN2.2 experiments were normalized 
relative to the maximum for each culture, which was arbitrarily set at 100 %. For raw 
chemiluminescence data in mPer2Luc cells the data was not normalized but both were 
subjected to a Lomb-Scargle Fourier transform analysis using AutoSignal software (Systat 
Software Inc., Point Richmond, CA, USA). A least-square fitting of the data was applied 
with a sinusoidal parametric function. Through regression analysis at various frequencies, 
the period (τ) of recurrent oscillations was extracted from the time series data, with 
significant periods ranging from 22 to 26 hours in the case of experiments that used 
SCN2.2 cells . In most cases paired and pooled t-tests were performed to determine if 
changes in ATP levels were significantly different between peak and trough times. For 
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treatment groups one-way ANOVA was performed of fluorescence intensity and cytokine 
levels to find differences across time-points. Two-way ANOVA was used when testing 
differences between treatment groups across time. Tukey’s HSD post hoc test was used 
when significant differences were found. For highest and lowest levels of fluorescence 
intensity and cytokine levels, a t-test was performed. All statistical analyses were done 
using R programming language and software. The value was set at 0.05 for significant 
differences for all statistical analyses. 
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RESULTS 
Specific activation of P2X7R increases extracellular ATP levels in mPer2LucSCN cells 
Previous studies performed in our lab demonstrated that astrocytes possess an endogenous 
rhythm in extracellular ATP accumulation in rat SCN cells in vitro and in vivo, as well as 
in mouse cortical glial cells in vitro (Womac et al. 2009). In the present study, I 
investigated the effect of purinergic receptor activation on the accumulation of 
extracellular ATP in a mouse SCN cell line (mPer2LucSCN). I used either ATP (10nM) or 
BzATP (10nM and 100µM) to activate all responsive purinergic signaling pathways or 
specifically the P2X7 purinergic receptor expressed in these mouse cells, respectively 
(Iglesias et al. 2008, Iglesias et al. 2009, Jackson et al. 2014). I observed that acute 
exposure of the mSCN cells to 100 µM BzATP produced a chemiluminescence signal 
(photons of light per second) orders of magnitude greater than either 10 nM ATP or 10 
nM BzATP (Fig. 4). These results indicate that BzATP at the higher pharmacological 
concentration (100 µM) induces an increase in ATP release from SCN astrocytes. 
Furthermore, physiological concentrations of ATP (10 nM), or its analog, are not 
significantly different in their effects on the chemiluminescence assay. It is also important 
for my subsequent studies to note that 100 µM BzATP induced an increase in extracellular 
ATP, as reported by the chemiluminescence assay, that was detectable for greater than 60 
min, although the intensity of the signal had significantly declined. 
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Figure 4. Acute effects of ATP and BzATP application on ATP dependent 
chemiluminescence using mPer2Luc cells.  After 5 and 30min, the average 
chemiluminescence produced after BzATP (100µM) is significantly higher 
than the one produced by ATP (10nM) (*p<0.05, n=4). Note the difference 
in scales. Error bars represent 95% confidence intervals.  
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Since chemiluminescence assays have been used to determine extracellular ATP 
accumulation in cell culture medium, I performed experiments to determine if the light 
produced in these assays was a result of ATP release from the SCN cells, or a product of 
direct activation of the chemiluminescence reaction by the exogenous ATP or BzATP 
molecules. When comparing ATP and BzATP as direct substrates for the 
luciferase/luciferin reaction, the average chemiluminescence produced by ATP (100 µM) 
was 93% greater than the light generated by BzATP (100 µM; Fig.5), demonstrating that 
in the absence of medium from living cells BzATP is far less effective than ATP is driving 
the luciferin/luciferase reaction. Additionally, chemiluminescence assays conducted on 
medium sampled from culture dishes with and without SCN cells demonstrated that 
application of BzATP to those dishes only produced significant ATP-dependent signal 
when cells were present (Fig. 6). Thus, significant elevations in the extracellular 
accumulation of ATP in mPer2LucSCN cell cultures, following BzATP application, is due 
to P2X7R activation and not due to direct BzATP-dependent activation of the 
chemiluminescence assay. 
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Figure 5. Direct chemiluminescence responses to ATP and BzATP. The 
capacity of both ATP and BzATP (100 µM) to drive the luciferase/luciferin 
chemiluminescence reaction was compared. ATP produced a 93% greater 
luminescence signal than BzATP (*p<0.05, n=4). Note the different scales 
between the ATP and BzATP histograms. Error bars represent 95% 
confidence intervals. 
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Figure 6. Chemiluminescence after BzATP (100µM) application to dishes 
with and without mPer2Luc SCN cells. The average chemiluminescence 
intensity produced after BzATP (100µM) application in the presence of cells 
was significantly greater than the chemiluminescence produced by BzATP 
(100µM) alone (*p<0.05, n=4). Error bars represent 95% confidence 
intervals. 
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Exogenous ATP alters the amplitude of astrocytic ATP release rhythms 
Rat SCN2.2 cells possess rhythms in extracellular ATP accumulation, which likely require 
the synchronous release from many astrocytes (Womac et al., 2009). Furthermore, 
antagonism of the P2X7 receptor dampens both ATP release and PER2 gene expression 
rhythms in mammalian SCN cell cultures (Womac et al., unpublished). Since my previous 
experiments demonstrated that ATP and its analog BzATP evoke robust elevations in 
extracellular ATP accumulation, I hypothesize that ATP, signaling through the P2X7 
receptor, enhances the ensemble release rhythm of SCN astrocytes. To test this idea, I 
applied exogenous ATP (10nM) at two specific times that corresponded to the predicted 
peak and trough of the extracellular ATP rhythm in SCN2.2 cell cultures. ATP elicited 
opposing effects on the subsequent cycles of the endogenous ATP rhythm depending on 
the time of exposure.  
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At the peak (6hr) timepoint, application of ATP in 10 out of 12 cell cultures exhibited high 
amplitude rhythmicity in extracellular ATP accumulation in medium samples, with peaks 
occurring at approximately 24-hour intervals. These ATP release rhythms persisted for at 
least 3 cycles and, based on Fourier transform analyses, the mean (±SEM) period (τ) was 
24.6 ± 0.2 hours (Fig. 7A), calculated from the 10 cultures with significant rhythmicity. In 
contrast to cultures treated with exogenous ATP, only 6 out of 12 naïve control cell cultures 
were rhythmic and had a mean (±SEM) period (τ) of 22.7 ± 0.3 h, which was significantly 
shorter than culture dishes exposed to exogenous ATP at peak (Fig. 7C and 8A). 
Furthermore, all 12 SCN2.2 cell cultures exposed to ATP (10 nM) application at the trough 
(16hr) timepoint were arrhythmic (Fig. 7C). With respect to rhythm amplitude, the mean 
extracellular ATP at the first cycle after ATP application (peak to trough comparison was 
significantly different in the peak-treated, but not trough treated cultures (Fig. 8B).   
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Figure 7. Effects of exogenous ATP application on SCN2.2 cell culture ATP accumulation rhythms. ATP (10 
nM) was applied at peak and trough levels of the endogenous extracellular ATP rhythm. A) Cell cultures were 
exposed to ATP at the peak (6hr) timepoint of the rhythm, when extracellular levels were predicted to be greatest 
(n=12). This time series represents the averaged and normalized ATP chemiluminescence for all cultures. B) 
ATP-dependent chemiluminescence time series in control cell cultures that received neurobasal medium at either 
6h or 16h (vehicle; 500 µl) as treatment (n=12). C) ATP-dependent chemiluminescence time series in cell cultures 
exposed to ATP at the trough (16hr) timepoint, when ATP levels of the rhythm were at their predicted low (n=12). 
Dashed lines represent projected ATP peaks with a 24h rhythmicity. 
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Figure 8. Circadian properties of the extracellular ATP accumulation 
rhythms. A) Comparison of mean (±SEM) period (τ) of cell cultures 
exposed to ATP at the peak of the ATP release rhythm (n=10) and control 
cell cultures  (n=6). Analyses of the individual cultures revealed that the 
average rhythm frequency with power above critical limits in a Lomb-
Scargle Fournier transform was 0.04065, indicative of a circadian 
rhythmicity with a period of 24.6h. The period in the 10 ATP-treated 
cultures was significantly longer than that observed in the 6 rhythmic 
control cultures (*p<0.05). B) Comparison of the mean ATP-dependent 
chemiluminescence in medium from peak and trough timepoints of cells at 
the first cycle following treatment with exogenous ATP (10 nM) at peak 
levels. Levels of extracellular ATP were significantly different (n=12; 
*p<0.05) between first cycle peak and trough. Error bars represent 95%
confidence intervals. 
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Since BzATP, a specific agonist of the P2X7R, induced a pronounced increase in ATP 
release from mouse mouse mPer2LucSCN cells, I investigate whether activation of the 
P2X7 receptor alone by this agonist could enhance ATP release rhythms in the mouse 
SCN cell line. Cultures exposed to BzATP (100uM) regularly possessed a peak in ATP 
release 24-28h following the exogenous treatment (Fig. 9A). Based on Fourier transform 
analyses, none of the 6 mSCN cell cultures were rhythmic. Still, most cultures possessed 
a frequency that was near circadian in rhythmicity, although not above significant critical 
limits, with a mean estimated period of 26.2 ± 0.7 h). Control mSCN cell cultures that 
received only vehicle treatment were not rhythmic either according to Fourier transform 
(Fig. 9B), nor did they exhibit a high amplitude peak in ATP release near the 24-28h 
timepoints. Thus, BzATP likely induced a synchronous release of ATP with a time delay 
of approximately 24h in mouse SCN astrocytes. 
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Figure 9. Effects of BzATP application on mPer2Luc SCN cells. A) Cell cultures receiving BzATP (100 µM) 
treatment at the 6h time had a robust peak in ATP-dependent chemiluminescence at approximately 24h following 
the P2X7 agonist exposure (n=6). B) Control cell cultures exposed to only the neurobasal medium vehicle (500 
µl) at the same time-point had no rise in ATP chemiluminescence at 24h following treatment (n=6). 
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P2X7R activation potentiates amplitude of clock gene reporter rhythms 
Since P2X7R antagonists disrupt clock gene expression rhythms in the mPer2Luc SCN 
reporter cell line, I investigated whether a pharmacological dose of the P2X7R agonist, 
BzATP, would also alter clock gene expression rhythms. BzATP (100 µM), whether 
applied to mSCN cells at the peak of the endogenous ATP release rhythms significantly 
shortened the period of the PER2::LUC rhythm (21.9 ± 0.3; mean ± SD; n=4) by almost 
one hour, as compared to control (vehicle-treated) rhythm period of 22.5 ± 0.3 (n=4; 
p<0.05). Treatment with BzATP at the trough of the ATP rhythm has no significant impact 
on gene expression periodicity. 
Interestingly, BzATP (100 µM) caused a marked increase in the amplitude of the 
PER2::LUC rhythm when applied at times corresponding to either peak or tough of the 
ATP release rhythm. This potentiation was likely due to activation of the P2X7R-
mediated signaling pathway, and not direct enhancement of the luciferase reporter, since 
parallel cultures treated with ATP (10 nM) at a dose that drives chemiluminescence to a 
similar extent as the higher analog dosage, had no effect on the PER2::LUC rhythm 
(Fig. 10A). The increase in PER2::LUC rhythm amplitude was four-fold when BzATP 
was applied at the ATP release peak, compared to the ATP-treated cultures (p<0.05; Fig. 
10B). A smaller, but also significant, increase in rhythm amplitude was induced by the 
P2X7R agonist when applied at the ATP release trough (p<0.05; Fig. 10B). Thus, 
activation of the P2X7R with BzATP causes both an increase in amplitude and a 
decrease in the period of PER2::LUC rhythms in mouse SCN astrocytes in culture. 
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Figure 10. P2X7 receptor activation potentiates PER2::LUC rhythms in 
mPer2Luc SCN cells. A) Bioluminescence data from mouse PER2::LUC 
SCN reporter cells show oscillations in clock gene expression. Application 
of 100 µM BzATP at the peak of the endogenous ATP release rhythm causes 
an increase in rhythm amplitude (3 representative cultures in top records). 
Treatment with 10 nM ATP had no effect on rhythm amplitude (2 
representative bottom records). B) Comparison of mean bioluminescence 
amplitudes demonstrates that BzATP caused a significant increase at both 
peak and trough time of exposure, compared to ATP-treated cells (*p<0.05; 
n=4). Error bars represent standard deviation. 
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P2X7R expression is rhythmic in mPer2Luc cells 
The rhythmic oscillation in ATP release from SCN cell lines, the modification of this 
rhythm’s circadian properties by exogenous ATP, and the capacity of a P2X7 agonist to 
elicit acute and 24h-delayed rises in ATP release together suggest that ATP sensing in 
SCN astrocytes varies by time of day. To address this possibility, I conducted 
immunocytochemical analyses of P2X7R protein expression in mPer2Luc SCN cells. P2X7 
immunoreactivity was markedly rhythmic in cells permeabilized with Tween 
(polysorbate) 20 detergent (Fig. 11A). Since P2X7 immunoreactivity was only performed 
for a 48 hours at 4-hour intervals, I cannot determine rhythmicity using Fourier transform, 
but levels of immunofluorescence changed depending on time.  That is, average trough 
values of immunofluorescence intensity were observed 24 hours apart at T8 and T32 (Fig. 
11B). Average peaks in immunofluorescence were observed 20 hours apart at T20 and 
T40. Trough and peak protein expression differences, as indicated by the 
immunoreactivity, were statistically significantly (p<0.05; Fig. 11C). Thus, P2X7R 
expression in mouse SCN astrocytes is rhythmic, likely in a circadian manner. 
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Figure 11. P2X7 receptor expression in mPer2Luc SCN cells. A) Immunoreactivity was visualized with 
fluorescence microscopy at 4-hour timepoints over 48 hours of mPer2Luc SCN cell culture. Images depict P2X7 
antibody detection in confluent cell cultures. Scale bar is 10µm.  B) Fluorescence intensity of the P2X7R 
immunoreactivity was rhythmic with peaks and troughs approximately 12h apart. C) Mean fluorescence intensity 
at timepoints T8 (trough) and T20 (peak) were significantly different (*p<0.05; n=4), with 68% higher 
fluorescence intensity at peak compared to trough. Error bars represent 95% confidence intervals. 
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Time-dependent astrocytic activation and cytokine release 
The P2X7 receptor is recognized as an important cell surface regulator of neural 
inflammatory signaling (Lister et al., 2007). ATP signaling, via the P2X7 receptor, 
mediates activation of astrocytes during brain trauma or disease (Rodrigues et al., 2015). 
This activation, or astrogliosis, is accompanied by upregulated expression of glial 
fibrillary acidic protein (GFAP), a process inhibited by P2X7R antagonism (Grygorowicz 
et al., 2016). Since rhythmic GFAP expression in rat SCN astrocytes has been observed 
in vivo (LaVialle & Serviere 1993) and I demonstrate here rhythmic P2X7R expression in 
mouse SCN cells, I tested whether GFAP expression was rhythmic in the mPer2Luc SCN 
cell line. The GFAP immunoreactivity in these mSCN cells oscillated with peak (T36) and 
troughs (T24 and T48) and had time lags of approximately 12 hours between peak and 
trough (Fig. 12A). The astrocytic expression of GFAP, as indicated by immunoreactivity, 
was cytoplasmic (Fig. 12B). Further, this cytoplasmic expression of the glial protein was 
significantly different between peak and trough timepoints (p<0.05; Fig. 12C).  
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Figure 12. Immunoreactivity of GFAP antibody in mPer2Luc SCN cells. A) 
fluorescence microscopy at 4-hour timepoints over 48 hours of mPer2Luc 
SCN cell culture. B) Images depict GFAP antibody detection, which is 
cytoplasmic, at T24 (trough) and T36 (peak) timepoints. Blue fluorescence 
represents DAPI staining. Scale bar is 10µm. C) Mean fluorescence intensity 
of the GFAP immunoreactivity at time-points T24 and T36 (n=4) were 
significantly different (*p<0.05), with 86% higher fluorescence intensity at 
peak compared to trough. Error bars represent 95% confidence intervals. 
0.0
5000.0
10000.0
15000.0
20000.0
25000.0
0 4 8 12 16 20 24 28 32 36 40 44 48 52
Fl
uo
re
sc
en
ce
 In
te
ns
ity
Time (hours)
A
48 
Figure 12 Continued 
0
5000
10000
15000
20000
25000
30000
Fl
uo
re
sc
en
ce
 in
te
ns
ity
Trough
Peak
T24  T36
*
C
T24 T36 
B 
49 
Since P2X7R is known to regulate neuroinflammatory signaling, including the release of 
the glial cytokine interleukin-1β (Il-1β; Lister et al., 2007), I tested whether treatment of 
mouse SCN astrocytes with the receptor agonist BzATP would induce Il-1β secretion in 
a time-dependent manner. Medium samples collected from mPer2Luc SCN cells at 4 
different time-points were analyzed by ELISA for the levels of the cytokine interleukin-
1β (Il-1β) that accumulated in the cell culture medium. Media samples from control 
mSCN cells, which received neurobasal medium vehicle treatment only, exhibited 
variable levels of Il-1β depending on time of culture (Fig. 13A). The peak of Il-1β 
secretion was detected at T6 and was significantly greater than (p<0.05) all other 
timepoints, including the Il-1β secretion trough at T18. BzATP treatment (100 µM), rather 
than elevating cytokine release, abolished the enhanced level of IL-1β at T6, and the 
associated significant differences in cytokine secretion across timepoints (Fig. 13B). 
Furthermore, when comparisons between control and experimental groups were 
conducted, a significant difference in Il-1β release was observed at the 6h timepoint 
(p<0.05). Thus, astrocyte activation in SCN cell cultures is endogenously rhythmic with 
regard to GFAP expression and Il-1β release, both peaking at T6, and P2X7R activation 
with BzATP disrupts the ensemble secretion fluctuation in Il-1β release.  
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Figure 13. Extracellular IL-1β accumulation in mPer2Luc SCN cell culture 
media is time-dependent. A) Mean IL-1β level at T6 in medium samples 
from control (untreated) mSCN cultures was significantly different from the 
other 3 collection time-points (n=12; *p<0.05). Error bars represent 95% 
confidence intervals. B) Following exposure to BzATP (100 µM), IL-1β 
levels were not significantly different across time-points (n=8). Error bars 
represent standard deviation. C) At time-point 6h (T6), the mean IL-1β level 
was significantly different between the control (n=12) and BzATP-treated 
cells (n=8; *p<0.05). Error bars represent 95% confidence intervals. 
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CONCLUSIONS 
Circadian rhythms in neuronal physiology and gene expression are coordinated among 
SCN neurons (Hastings and Herzog, 2004). These SCN rhythms are necessary for 
expression of entrained circadian oscillation in animal physiology and behavior. Although 
some mechanisms regulating signaling among neurons are understood, mechanisms of 
glial signaling within the SCN are virtually unknown. Since a circadian rhythm in the 
accumulation of extracellular ATP was first described (Womac et al. 2009), it is thought 
that clock-controlled gliotransmission is not vesicular (Marpegan et al. 2011), but still 
requires calcium signaling (Burkeen et al. 2011). Furthermore, P2X7R inhibition 
abolishes the ATP release rhythms in rat SCN cells and dampens rhythms in PER2 gene 
expression in mouse SCN cells (Womac et al. unpublished). I used a potent P2X7R 
agonist, BzATP, to trigger an acute (less that 5 min) and robust (many orders of 
magnitude) increase in ATP release from immortalized mouse SCN cells. 
A possible role of clock-controlled ATP release is in the coordination of ensemble 
astrocyte physiology in the SCN and other brain regions. ATP acts as an important 
signaling molecule between astrocytes and neurons (Parpura & Haydon 2000) and, 
therefore, is a good candidate for a synchronizing signal among individual oscillating 
astrocytes. Exogenous ATP alters the ATP release rhythm in rat SCN2.2 cells, where ATP 
application during peak times of the rhythm enhances subsequent release cycles. In 
contrast, when cell cultures received ATP during trough times the ATP accumulation 
rhythm was completely abolished. These results suggest that ATP may have served as a 
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signaling molecule that coordinates, and possibly contributes to the synchronization, of 
ensemble and clock-controlled astrocyte physiology. Interestingly, the period (τ) of the 
ATP release rhythm was significantly longer in the ATP peak-treated cells  (24.6h), as 
compared to controls (22.7h). This result may set preliminary data for ATP as a 
synchronizer molecule that can cause phase shifts in the extracellular ATP accumulation 
rhythm and other physiological processes that require clock-controlled ATP signaling. 
ATP release rhythms in SCN astrocytes are calcium-dependent (Burkeen et al. 
2011) and P2X7R activation of calcium influxes is time-dependent (Womac et al. 
unpublished). Since P2X7R are necessary for these ATP release rhythms, BzATP was 
applied to mouse SCN cell cultures at the peak time of the ATP rhythm causing an 
additional peak of ATP release following a 24h delay. Additionally, BzATP at the peak 
of the ATP rhythm, but not the trough, causes a change in the period of the rhythm of 
PER2 gene expression (Camacho et al. data not shown). Thus, clock-controlled ATP 
signaling by SCN astrocytes might be modulated by a similarly clock-controlled ATP 
sensitivity rhythm in these glial cells. Another important thing to consider is that the 
application of ATP (10nM) had an effect on the extracellular ATP accumulation rhythm 
but not on the PER2 expression rhythm. This means the rhythmicity of the molecular clock 
is not disrupted by ATP, but the extracellular ATP accumulation rhythm is affected. 
P2X7R expression is shown here to be rhythmic in mSCN astrocytes, shedding 
light on the mechanism of ATP-dependent communication among these glial cells., The 
trough of P2X7R expression at T8 was significantly different from the peak at T20. 
Therefore, these data demonstrate that the rhythm in P2X7R expression is anti-phasic with 
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the rhythm in extracellular ATP release. This result suggests that oscillations in 
extracellular ATP accumulation are not the only clock-controlled component of this glial 
signaling mechanism, since purinergic receptor availability may also be rhythmic in the 
SCN. It should be noted that no experiments were conducted here to determine if 
membrane localization of P2X7R or if P2X7r gene expression are rhythmic in these 
astrocyte cultures, and thus my interpretations are limited. 
It was important in these studies using luciferase assays to rule out the possibility 
that BzATP merely drives the luciferase/luciferin reaction directly, rather than enhancing 
ATP-dependent rhythms. ATP-activated chemiluminescence, at same concentrations as 
BzATP, caused significantly higher levels of light production, suggesting that BzATP is 
not as efficient as ATP in driving the assay reaction. When the same concentration of 
BzATP (100 µM) was applied in the presence of cultured SCN cells, the 
chemiluminescence intensity was significantly greater than when performed in the 
presence of the luciferase/luciferin substrates alone. Thus, P2X7R activation is clearly 
mediating, as least in part, the ATP signaling underlying clock-controlled rhythms among 
SCN astrocytes. 
Another important fact to consider is that BzATP has been widely used as a P2X7R 
agonist to study its role in partnership with PANX1 in astrocytic communication through 
ATP release and inflammatory responses (Qiu & Dahl 2009, Iglesias et al. 2008). The 
increased light production after BzATP application discovered here further suggests its 
efficacy in activating P2X7R modulation of the clock-controlled ATP release rhythm. 
Preliminary studies indicate that PANX1 expression may be also rhythmic in mSCN cells 
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and in phase with P2X7R (data not shown). This is important evidence in that the rhythmic 
regulation of P2X7R and PANX1 and their rhythmic regulation in mouse astrocytes may 
underlie circadian aspects of the brain’s neuroinflammatory signaling.  
ATP signaling in astrocytes, like many other cellular signaling mechanisms, is 
most likely involved in modulating several physiological processes in the brain. The 
extracellular ATP release rhythm is probably utilized for greater intercellular 
communication than just among astrocytes. That is, it may also be involved in astrocyte-
microglia communication, critical in immune responses of the brain. One of the most 
widely used markers for astrocytic activation during neuroinflammation is increased 
GFAP expression. During this state of activation, astrocytes and microglia become 
reactive and promote neuro-inflammation. This neuroinflammatory response is 
characterized by astrocytes upregulating GFAP expression and microglia signaling for 
cytokine release from microglia or astrocytes. Thus, I was interested in determining if 
mouse SCN Per2Luc cells express GFAP rhythmically, as has been reported for the rat SCN 
in vivo (La vialle & Serviere 1993). Mouse SCN cells showed variability in GFAP 
expression that was time-dependent. It is interesting to note that clock-defective SCN cells 
and astrocytes in other brain regions, through Bmal1 deletion, have abnormal levels of 
GFAP expression that are maintained in an upregulated state (Musiek et al. 2013). This 
also supports the idea that neuroinflammation may be clock-controlled, since 
arrhythmicity causes increases in astrocytic activation. Preliminary data incubating mouse 
SCN cells with BzATP before performing immunocytochemical analyses with GFAP 
antibodies suggest that purinergic receptor activation causes either an increase or decrease 
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in GFAP expression in a time-dependent manner. It will be interesting to further continue 
that experiment and define more of the mechanistic features of these potential astrocyte-
microglia interactions. 
As mentioned previously, P2X7R in astrocytes and microglia is involved in 
immune responses that are ATP dependent (Jackson et al. 2014). One of those immune 
responses is the release of cytokine IL-1β (Bianco et al. 2005). ATP stimulation enhances 
release of IL-1β, which is blocked with P2X7R inhibitors. Most of the literature agrees
that IL-1β release though modulated by P2X7R activation, is not physically released 
through the ionotropic receptor, but in fact through the pore forming PANX1 channel. 
This further suggests that ATP signaling through P2X7R is involved in several astrocytic 
physiological processes, such as eliciting immune responses in partnership with microglia. 
Therefore, I investigated if IL-1β can be detected in mouse SCN medium and, more 
importantly, if it is rhythmically accumulated. The mean levels of IL-1β had a peak in 
accumulation at T6. This peak was significantly higher than all other timepoints tested. I 
also incubated cells with BzATP and this purinergic receptor agonist abolished the 
cytokine oscillation. This means that P2X7R activation in SCN mPer2Luc cells can elicit 
different responses in terms of IL-1β accumulation. It will be interesting to do an extended 
time course studies of this cytokine, since IL-1β transcript has been found to be rhythmic 
in mouse SCN (CircaDB, Circadian Expression Profiles Data Base). Other astrocytic 
activation markers, such as TNF-α can alter clock gene expression and possibly have a 
role in modulating circadian immune responses (Duhart et al. 2010). Therefore, it is 
possible that cytokine release, such as that of IL-1β by SCN glial cells, can be clock-
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controlled and possibly regulated through circadian ATP release and P2X7R signaling 
complex. 
In summary, ATP signaling among astrocytes is a good candidate for a 
coordinating mechanism that synchronizes clock-controlled physiological responses in 
the SCN and other brain regions. Furthermore, I present data indicating that clock-
controlled ATP signaling rhythms are involved in modulating neuroinflammatory 
signaling. Since BzATP proved to be an effective P2X7R agonist with regard to 
potentiating ATP release from mouse SCN cells, further experiments with other agonists 
and antagonists could provide evidence for the role of ATP and P2X7R signaling 
rhythms, their circadian regulation, and their influence on astrocytic physiology and 
brain health. 
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